Evidence map›Paper›PMID 26385698›Full record

ArticleBMC genomics2015

Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology.

Jinsheng Yu, Paul F Cliften, Twyla I Juehne, Toni M Sinnwell, Chris S Sawyer, Mala Sharma, Andrew Lutz, Eric Tycksen, Mark R Johnson, Matthew R Minton and 6 more

Abstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. MTHFR regulatory effects on methylation of CG05575921 in response to smoking: Effects are also discernable using MTHFR expression.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2018
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jinsheng YuGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Paul F CliftenGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Twyla I JuehneGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Toni M SinnwellGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Chris S SawyerGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Mala SharmaGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Andrew LutzGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Eric TycksenGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Mark R JohnsonGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Matthew R MintonGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Elliott T KlotzGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Andrew E SchrieferGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Wei YangGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Michael E HeinzGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Seth D CrosbyGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA.
Richard D HeadGenome Technology Access Center, Department of Genetics, Washington University in Saint Louis School of Medicine, 660 S. Euclid Ave. Campus Box 8232, Saint Louis, MO, 63110, USA. rhead@genetics.wustl.edu.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
NCATS NIH HHS UL1 TR000448NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1RR024992
6 · The paper itself

Abstract

backgroundThe arrival of RNA-seq as a high-throughput method competitive to the established microarray technologies has necessarily driven a need for comparative evaluation. To date, cross-platform comparisons of these technologies have been relatively few in number of platforms analyzed and were typically gene name annotation oriented. Here, we present a more extensive and yet precise assessment to elucidate differences and similarities in performance of numerous aspects including dynamic range, fidelity of raw signal and fold-change with sample titration, and concordance with qRT-PCR (TaqMan). To ensure that these results were not confounded by incompatible comparisons, we introduce the concept of probe mapping directed "transcript pattern". A transcript pattern identifies probe(set)s across platforms that target a common set of transcripts for a specific gene. Thus, three levels of data were examined: entire data sets, data derived from a subset of 15,442 RefSeq genes common across platforms, and data derived from the transcript pattern defined subset of 7,034 RefSeq genes.

resultsIn general, there were substantial core similarities between all 6 platforms evaluated; but, to varying degrees, the two RNA-seq protocols outperformed three of the four microarray platforms in most categories. Notably, a fourth microarray platform, Agilent with a modified protocol, was comparable, or marginally superior, to the RNA-seq protocols within these same assessments, especially in regards to fold-change evaluation. Furthermore, these 3 platforms (Agilent and two RNA-seq methods) demonstrated over 80% fold-change concordance with the gold standard qRT-PCR (TaqMan).

conclusionsThis study suggests that microarrays can perform on nearly equal footing with RNA-seq, in certain key features, specifically when the dynamic range is comparable. Furthermore, the concept of a transcript pattern has been introduced that may minimize potential confounding factors of multi-platform comparison and may be useful for similar evaluations.

Indexed as

Gene Expression ProfilingOligonucleotide Array Sequence AnalysisReproducibility of ResultsRNARNA

Identifiers

PMID26385698
PMCPMC4575490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.